MENU
CGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Compugen (CGEN) Ownership - Who owns Compugen?
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
68
Web
https://www.cgen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
156.55M
P/E Ratio
60.33
Total Cash
103.75M
Projected Growth
N/A
Total Debt
2.77M
Revenue
27.59M
Risk (Beta)
3.09
Dividend Yield
N/A
Total Cash/Share
1.11
Total Debt/Equity
N/A
Revenue/Share
0.31 USD as % of share price
Fundamentals
CGEN
Capitalization
157M
P/E Ratio
60.33
Risk (Beta)
3.09
Dividend Yield
N/A
Total Cash
104M
Total Cash/Share
1.11
Total Debt
2.77M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.31%
Revenue
27.6M
ROE
N/A
Book Value
57.1M
P/B Ratio
2.72
Cash Flow
N/A
Earnings
-0.16
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
248K
Current Ratio
5.09
Current Revenue Per Employee
30864.87
Dividends Per Share - Security
N/A
EBITDA
-14.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
-5.08
Revenue To Assets
-12.35
Shares Held By Institutions
9.84M
Shares Outstanding - Current
93.5M
Total Liabilities
58.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
8.497
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a maker of drug and diagnostics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
68
Web
https://www.cgen.com